Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Discovery of potent and selective p53-MDM2 protein-protein interaction inhibitors as anticancer drugs

Holzer, Philipp (2017) Discovery of potent and selective p53-MDM2 protein-protein interaction inhibitors as anticancer drugs. Chimia : international journal for chemistry, 71 (10). pp. 716-721. ISSN 0009-4293

Abstract

As a result of our efforts to discover novel inhibitors of the p53-MDM2 protein-protein interaction useful for the treatment of cancer, the potent and selective MDM2 inhibitors NVP-CGM097 and NVP-HDM201 with excellent in vivo profile were selected as clinical candidates and are currently in phase 1 clinical development. This review article provides an overview of the program history, the applied pharmacophore model and the discovery story of these novel p53-MDM2 inhibitor investigational drugs.

Item Type: Article
Date Deposited: 07 Dec 2017 00:45
Last Modified: 07 Dec 2017 00:45
URI: https://oak.novartis.com/id/eprint/33494

Search